首页>投融资
SciTech Development
未透露
SciTech Development is a privately held pharmaceutical company, founded in 2002, which focuses on optimizing previously shelved anticancer drugs and developing them for specific indications.In June 2023, SciTech Development LLC closed a $2.73 million funding round
基本信息
-
公司全称SciTech Development LLC
-
类型肿瘤类药物制造商
-
产业领域药品研发/制造、研发制造服务、生物药
-
公司人数15人以下
-
地址281 Kercheval Ave GROSSE POINTE FARMS MICHIGAN 48236-3105; US; Telephone: +13132634887;
-
联系电话13139667317
-
邮箱eth@scitechdevelopment.com
-
成立时间2001-01-01
投融资
-
2024-06-04未透露320万美元Storm Lake CapitalPointe Angels
-
2023-06-07未透露273万美元The National Foundation for Cancer ResearchHRN Family OfficeStorm Lake CapitalPointe Angels
相关投融资企业
增发
NurExone Biologic, formerly known as EnerSpar (which merged with NurExone Biologic Ltd), is a biopharmaceutical company focused on developing biologically-guided exosome therapy for patients with traumatic spinal cord injuries.In June 2022, the company completed a reverse merger with NurExone Biologic Ltd. The common shares in the capital of the Company were consolidated with each 10 pre-consolidation common shares being exchanged for 1 post-consolidation common share. As a condition of closing, the company completed a plan of arrangement on May 31, 2022, pursuant to which the company spun out its wholly-owned subsidiary 1222150 BC Ltd, including the former mining assets of the company
上市后再融资
Sk Bioscience Co Ltd is a spun-out and a fully owned subsidiary of SK Inc, is a biopharmaceutical company with the main focus on vaccines.In November 2022, SK Bioscience Co Ltd donated 3 billion won to International Vaccine Institute to advance global vaccine research and development
增发
Silo Pharma, Inc.于2010年7月13日在纽约州注册成立。2013年1月24日,公司将其注册地从纽约州变更为特拉华州。该公司是一家处于开发阶段的生物制药公司,专注于将传统疗法与迷幻研究相结合,以治疗患有阿尔茨海默氏症、创伤后应激障碍和其他罕见神经系统疾病等适应症的人。